Rifamycin-Based TB Prevention Regimens Have Lower Rate Of Adverse Events, Research Finds

Pulmonology Advisor (5/22, Stong) reports, “Mono-H regimens are associated with significantly higher rates of serious adverse events compared with rifamycin-based regimens among tuberculosis preventive therapy options, according to a study.” The findings...